{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T07:18:14Z","timestamp":1794813494295,"version":"4.9.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":236,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010481","name":"French Blood Organisation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010481","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["847939"],"award-info":[{"award-number":["847939"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"ANRS MIE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.jcmgh.2026.101870","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:31:48Z","timestamp":1788017508000},"page":"101870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis B Surface Antigen Directly Alters Dendritic Cell\u2013Mediated Natural Killer Cell Responses"],"prefix":"10.1016","volume":"20","author":[{"given":"Lucile","family":"Dumolard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Noelle","family":"Hilleret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mylene","family":"Pezet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Decaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Saas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Jouvin-Marche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice N.","family":"Marche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Aspord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2553-5971","authenticated-orcid":false,"given":"Zuzana","family":"Macek Jilkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2026.101870_bib1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","article-title":"Global reporting of progress towards elimination of hepatitis B and hepatitis C","volume":"8","author":"Cui","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101870_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nri.2016.69","article-title":"Immune responses and immunopathology in acute and chronic viral hepatitis","volume":"16","author":"Shin","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcmgh.2026.101870_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41575-022-00724-5","article-title":"The scientific basis of combination therapy for chronic hepatitis B functional cure","volume":"20","author":"Lim","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101870_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: an update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.jcmgh.2026.101870_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1189\/jlb.0912452","article-title":"Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness","volume":"93","author":"H\u00e9mont","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jcmgh.2026.101870_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fimmu.2013.00057","article-title":"NK cells: a double-edged sword in chronic hepatitis B virus infection","volume":"4","author":"Maini","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101870_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.canlet.2015.09.017","article-title":"TLR7\/8 agonists promote NK-DC cross-talk to enhance NK cell anti-tumor effects in hepatocellular carcinoma","volume":"369","author":"Zhou","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jcmgh.2026.101870_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910462","article-title":"Toll-like receptor response to hepatitis B virus infection and potential of TLR agonists as immunomodulators for treating chronic hepatitis B: an overview","volume":"22","author":"Kayesh","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcmgh.2026.101870_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/v9050095","article-title":"Interplay between the hepatitis B virus and innate immunity: from an understanding to the development of therapeutic concepts","volume":"9","author":"Faure-Dupuy","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.jcmgh.2026.101870_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3748\/wjg.v7.i4.537","article-title":"Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection","volume":"7","author":"Wang","year":"2001","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2026.101870_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fimmu.2019.00112","article-title":"Circulating and hepatic BDCA1+, BDCA2+, and BDCA3+ dendritic cells are differentially subverted in patients with chronic HBV infection","volume":"10","author":"Ouaguia","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101870_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161235","article-title":"The effect of chronic hepatitis B virus infection on BDCA3+ dendritic cell frequency and function","volume":"11","author":"van der Aa","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2026.101870_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026315","article-title":"Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells","volume":"6","author":"Vincent","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2026.101870_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015324","article-title":"Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function","volume":"6","author":"Woltman","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2026.101870_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1208","article-title":"Hepatitis B virus exploits C-type lectin receptors to hijack cDC1s, cDC2s and pDCs","volume":"9","author":"Ouaguia","year":"2020","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.jcmgh.2026.101870_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000625","article-title":"HBV and HBsAg strongly reshape the phenotype, function, and metabolism of DCs according to patients' clinical stage","volume":"9","author":"Dumolard","year":"2025","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jcmgh.2026.101870_bib17","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60095","article-title":"Peripheral natural killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion","volume":"10","author":"Marotel","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jcmgh.2026.101870_bib18","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3748\/wjg.v25.i16.1950","article-title":"Immune response pattern varies with the natural history of chronic hepatitis B","volume":"25","author":"Wang","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2026.101870_bib19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/liv.12272","article-title":"Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis B","volume":"34","author":"Tjwa","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jcmgh.2026.101870_bib20","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jcmgh.2015.09.004","article-title":"Natural killer cells in viral hepatitis","volume":"1","author":"Rehermann","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2026.101870_bib21","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/infdis\/jit561","article-title":"Compromised function of natural killer cells in acute and chronic viral hepatitis","volume":"209","author":"Lunemann","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcmgh.2026.101870_bib22","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1053\/j.gastro.2012.08.046","article-title":"Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection","volume":"143","author":"Martinet","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2026.101870_bib23","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1111\/liv.14885","article-title":"The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infection","volume":"41","author":"Du","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jcmgh.2026.101870_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1148111","article-title":"Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation","volume":"14","author":"Dumolard","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101870_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1489770","article-title":"Differences in the intrahepatic expression of immune checkpoint molecules on T cells and natural killer cells in chronic HBV patients","volume":"15","author":"Dumolard","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcmgh.2026.101870_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.intimp.2016.06.015","article-title":"Hepatitis B virus antigens impair NK cell function","volume":"38","author":"Yang","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jcmgh.2026.101870_bib27","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1182\/blood-2005-03-1154","article-title":"Natural-killer cells and dendritic cells: \u201cl'union fait la force\u201d","volume":"106","author":"Walzer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jcmgh.2026.101870_bib28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000323923","article-title":"The bidirectional crosstalk between human dendritic cells and natural killer cells","volume":"3","author":"Wehner","year":"2011","journal-title":"J Innate Immun"},{"key":"10.1016\/j.jcmgh.2026.101870_bib29","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2010.11.020","article-title":"Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual","volume":"33","author":"Swiecki","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jcmgh.2026.101870_bib30","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1182\/blood-2006-02-004028","article-title":"Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses","volume":"108","author":"Della Chiesa","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jcmgh.2026.101870_bib31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/hep.31725","article-title":"Human hepatitis B virus negatively impacts the protective immune crosstalk between natural killer and dendritic cells","volume":"74","author":"De Pasquale","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101870_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113216","article-title":"Differentiation-associated ISG expression of NK cells in chronic viral infection","volume":"28","author":"Keller","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.jcmgh.2026.101870_bib33","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41598-020-58870-2","article-title":"Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2026.101870_bib34","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1056\/NEJMoa2405485","article-title":"Xalnesiran with or without an Immunomodulator in chronic hepatitis B","volume":"391","author":"Hou","year":"2024","journal-title":"N Engl J Med"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26001487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26001487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T06:33:00Z","timestamp":1794810780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X26001487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2352345X26001487"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101870","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B Surface Antigen Directly Alters Dendritic Cell\u2013Mediated Natural Killer Cell Responses","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101870"}}